FINHUB Insights

Zimmer Biomet Q3 FY25: where the revenue came from and where it went

The whole income statement of Zimmer Biomet for this quarter, as one diagram: what earned the revenue, and what it went on.

Period
Jul 1 – Sep 30, 2025
Reported
Nov 5, 2025 10-Q accession 0001193125-25-266884

Revenue$2.00B +10% year over year
Gross profit$1.44B 72% margin
Operating profit$0.35B 18% margin
Net profit$0.23B 12% margin
100% free

It's free. All of it.

A free account opens every diagram. We send one link to confirm your address, and that is the whole of it.

Already have an account? Sign in

The numbers

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 30, 2025).
ItemValueShare of revenueYear over year
Revenue 2.00 100% +10%
Knees 0.79 40% +6%
SET 0.54 27% +19%
Hips 0.51 25% +5%
Technology & data bone 0.16 8% +12%
Cost of revenue−0.5628%
Gross profit1.4472% margin+2pp
SG&A−0.8141%+2pp
Other−0.2814%+0pp
Operating profit0.3518% margin+2pp
Interest & other costs−0.07
Tax−0.05
Net profit0.23 12% margin−2pp

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

136 of 418 companies, most recently reported first